> top > projects > sentences > docs > PubMed:25064355 > annotations
sentences Home  

PubMed:25064355 JSONTXT 7 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-63 Sentence denotes A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis.
T1 0-63 Sentence denotes A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis.
TextSentencer_T2 64-322 Sentence denotes Oncogenic fusion of the RET (rearranged during transfection) gene was recently identified as a novel driver gene aberration not only for the development of thyroid carcinoma but also of lung adenocarcinoma, the most frequent histological type of lung cancer.
T2 64-322 Sentence denotes Oncogenic fusion of the RET (rearranged during transfection) gene was recently identified as a novel driver gene aberration not only for the development of thyroid carcinoma but also of lung adenocarcinoma, the most frequent histological type of lung cancer.
TextSentencer_T3 323-537 Sentence denotes This study constructed and analyzed transgenic mice expressing KIF5B-RET, the predominant form of RET fusion gene specific for lung adenocarcinoma, under the control of the SPC (surfactant protein C) gene promoter.
T3 323-537 Sentence denotes This study constructed and analyzed transgenic mice expressing KIF5B-RET, the predominant form of RET fusion gene specific for lung adenocarcinoma, under the control of the SPC (surfactant protein C) gene promoter.
TextSentencer_T4 538-674 Sentence denotes The mice expressed the KIF5B-RET fusion gene specifically in lung alveolar epithelial cells, and developed multiple tumors in the lungs.
T4 538-674 Sentence denotes The mice expressed the KIF5B-RET fusion gene specifically in lung alveolar epithelial cells, and developed multiple tumors in the lungs.
TextSentencer_T5 675-786 Sentence denotes Treatment of the transgenic mice with vandetanib, which is a RET tyrosine kinase inhibitor approved by the U.S.
T5 675-786 Sentence denotes Treatment of the transgenic mice with vandetanib, which is a RET tyrosine kinase inhibitor approved by the U.S.
TextSentencer_T6 787-1014 Sentence denotes Food and Drug Administration for the treatment of thyroid carcinoma, for 8 or 20 weeks led to a marked reduction in the number of lung tumors (3.3 versus 0 and 6.5 versus 0.2 per tissue section, respectively; P < 0.01, t-test).
T6 787-1014 Sentence denotes Food and Drug Administration for the treatment of thyroid carcinoma, for 8 or 20 weeks led to a marked reduction in the number of lung tumors (3.3 versus 0 and 6.5 versus 0.2 per tissue section, respectively; P < 0.01, t-test).
TextSentencer_T7 1015-1173 Sentence denotes The results suggest that the RET fusion functions as a driver for the development of lung tumors, whose growth is inhibited by RET tyrosine kinase inhibitors.
T7 1015-1173 Sentence denotes The results suggest that the RET fusion functions as a driver for the development of lung tumors, whose growth is inhibited by RET tyrosine kinase inhibitors.